» Articles » PMID: 33815205

Harnessing the Neurobiology of Resilience to Protect the Mental Well-Being of Healthcare Workers During the COVID-19 Pandemic

Overview
Journal Front Psychol
Date 2021 Apr 5
PMID 33815205
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Healthcare workers are at a high risk of psychological morbidity in the face of the COVID-19 pandemic. However, there is significant variability in the impact of this crisis on individual healthcare workers, which can be best explained through an appreciation of the construct of resilience. Broadly speaking, resilience refers to the ability to successfully adapt to stressful or traumatic events, and thus plays a key role in determining mental health outcomes following exposure to such events. A proper understanding of resilience is vital in enabling a shift from a reactive to a proactive approach for protecting and promoting the mental well-being of healthcare workers. Research in the past decade has identified six areas that provide promising leads in understanding the biological basis of individual variations in resilience. These are: (1) the key role played by the monoamines noradrenaline and serotonin, (2) the centrality of the hypothalamic-pituitary-adrenal axis in influencing stress vulnerability and resilience, (3) the intimate links between the immune system and stress sensitivity, (4) the role of epigenetic modulation of gene expression in influencing the stress response, (5) the role played by certain neuropeptides as a natural "brake" mechanism in the face of stress, and (6) the neurobiological mechanisms by which environmental factors, such as exercise, diet, and social support, influence resilience to subsequent life events. Though much of this research is still in its early stages, it has already provided valuable information on which strategies - including dietary changes, lifestyle modification, environmental modification, psychosocial interventions, and even pharmacological treatments - may prove to be useful in fostering resilience in individuals and groups. This paper examines the above evidence more closely, with a specific focus on the challenges faced by healthcare workers during the COVID-19 pandemic, and provides suggestions regarding how it may be translated into real-world interventions, as well as how the more tentative hypotheses advanced in this field may be tested during this critical period.

Citing Articles

Resilience Improves the Quality of Life and Subjective Happiness of Physiotherapists during the COVID-19 Pandemic.

Pigati P, Righetti R, Dourado V, Nisiaymamoto B, Saraiva-Romanholo B, Tiberio I Int J Environ Res Public Health. 2022; 19(14).

PMID: 35886573 PMC: 9317447. DOI: 10.3390/ijerph19148720.


Novel GxE effects and resilience: A case:control longitudinal study of psychosocial stress with war-affected youth.

Mulligan C, Clukay C, Matarazzo A, Hadfield K, Nevell L, Dajani R PLoS One. 2022; 17(4):e0266509.

PMID: 35377919 PMC: 8979449. DOI: 10.1371/journal.pone.0266509.


How do Vaccinators Experience the Pandemic? Lifestyle Behaviors in a Sample of Italian Public Health Workers during the COVID-19 Era.

Galle F, Quaranta A, Napoli C, Diella G, De Giglio O, Caggiano G Vaccines (Basel). 2022; 10(2).

PMID: 35214705 PMC: 8879067. DOI: 10.3390/vaccines10020247.


Hair cortisol change at COVID-19 pandemic onset predicts burnout among health personnel.

Marcil M, Cyr S, Marin M, Rosa C, Tardif J, Guay S Psychoneuroendocrinology. 2022; 138:105645.

PMID: 35134663 PMC: 8697418. DOI: 10.1016/j.psyneuen.2021.105645.

References
1.
Stein M, Choi K, Jain S, Campbell-Sills L, Chen C, Gelernter J . Genome-wide analyses of psychological resilience in U.S. Army soldiers. Am J Med Genet B Neuropsychiatr Genet. 2019; 180(5):310-319. PMC: 6551278. DOI: 10.1002/ajmg.b.32730. View

2.
Cotrin P, Moura W, Gambardela-Tkacz C, Pelloso F, Dos Santos L, de Barros Carvalho M . Healthcare Workers in Brazil during the COVID-19 Pandemic: A Cross-Sectional Online Survey. Inquiry. 2020; 57:46958020963711. PMC: 7550936. DOI: 10.1177/0046958020963711. View

3.
Lenze E, Mattar C, Zorumski C, Stevens A, Schweiger J, Nicol G . Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial. JAMA. 2020; 324(22):2292-2300. PMC: 7662481. DOI: 10.1001/jama.2020.22760. View

4.
Yehuda R, Spiegel D, Southwick S, Davis L, Neylan T, Krystal J . What I have changed my mind about and why. Eur J Psychotraumatol. 2016; 7:33768. PMC: 5106864. DOI: 10.3402/ejpt.v7.33768. View

5.
Pertille F, Ibelli A, Sharif M, Poleti M, Frohlich A, Rezaei S . Putative Epigenetic Biomarkers of Stress in Red Blood Cells of Chickens Reared Across Different Biomes. Front Genet. 2020; 11:508809. PMC: 7667380. DOI: 10.3389/fgene.2020.508809. View